16033-74-2Relevant articles and documents
New triazine bridged triads based on BODIPY-porphyrin systems: Extended absorption, efficient energy transfer and upconverted emission
Souza, Marcos C.,Santos, Carla I.M.,Mariz, Inês,Marques, Bruno S.,Machado, Luana A.,Pedrosa, Leandro F.,Cavaleiro, José A.S.,Neves, Maria G.P.M.S.,Mendes, Ricardo F.,Paz, Filipe A.A.,Martinho, José M.G.,Ma??as, Ermelinda
, (2021)
Two novel triads connecting a BODIPY to ethylenediamine substituted porphyrins via triazine linker have been synthesized and characterized. One of the triads is a linear D-A structure with one BODIPY (D) and one porphyrin (A) bridged by the triazine linke
Organic compound taking triazine and benzimidazole as cores and application thereof
-
Paragraph 0074; 0075; 0076; 0077, (2017/09/01)
The invention relates to an organic compound taking triazine and benzimidazole as cores and application thereof to an OLED (Organic Light Emitting Diode) device. The compound provided by the invention has relatively high glass transition temperature and m
Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives
Vijayaraghavan, Shilpa,Mahajan, Supriya
, p. 1693 - 1697 (2017/04/04)
A series of 4-anilinoquinoline triazine derivatives were designed, synthesized and screened for in vivo antimalarial activity against a chloroquine-sensitive strain of Plasmodium berghei. The compounds were further subjected to in vitro antimalarial activity against chloroquine-resistant W2 strain of Plasmodium falciparum and β-haematin inhibition studies. All the compounds exhibited in vivo antimalarial activity better than that shown by the standard drug, chloroquine. Twelve out of fifteen compounds showed better inhibition than that of chloroquine against chloroquine-resistant W2 strain of Plasmodium falciparum. Ten compounds showed β-haematin inhibition, better than that of chloroquine, with IC50 values in the range of 18–25?μM. One compound, 3k, was found to be better than artemisinin against W2 strain of Plasmodium falciparum and also displayed the best β-haematin inhibitory activity, thereby becoming eligible to be explored as a potential lead for antimalarial chemotherapy.